Transurethral resection with perioperative instillation of interferon-α or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: A prospective randomized multicenter study - Finnbladder III

Journal of Urology

Volumn 161, Issue 4, 1999, Pages 1133-1136

  Rajala, Pertti ^e   Liukkonen, Tapani ^e   Raitanen, Mika ^e   Rintala, Erkki ^e   Kaasinen, Eero ^e   Helle, Markku ^e   Lukkarinen, Olavi ^e   Forsell, T ^a   Hynninen, O ^b   Lehtoranta, K ^b   Talja, M ^b   Juusela, H ^c   Kajaani, ^d   Korhonen, H ^d  

^a KYMENLAAKSO CENTRAL HOSPITAL   (Finland)

^b PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^c District Hospital of Jorvi   (Finland)

^d SATAKUNTA CENTRAL HOSPITAL   (Finland)

^e NONE

Author keywords

Bladder; Carcinoma; Epirubicin; Interferon; Recurrence; Transitional cell

Indexed keywords

ALPHA INTERFERON; CYTOSTATIC AGENT; DOXORUBICIN; EPIRUBICIN; ETOGLUCID; THIOTEPA;

ARTICLE; BLADDER CANCER; CANCER PREVENTION; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURGICAL TECHNIQUE;

EID: 0344549448     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)61609-4     Document Type: Article

References (15)

1. Lutzeyer, W., Rübben, H. and Dahm, H.: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J. Urol., 127: 250, 1982.
2. Torti, F. M. and Luni, B. L.: The biology and treatment of superficial bladder cancer. J. Clin. Oncol., 2: 505, 1984.
3. Soloway, M. S. and Masters, S.: Urothelial susceptibility to tumor cell implantation. Influence of cauterization. Cancer, 46: 1158, 1980.
4. Sidransky, D., von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I. and Marshall, F.: Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252: 706, 1990.
5. Burnand, K. G., Boyd, P. J. R., Mayo, M. E., Shuttleworth, K. E. D. and Lloyd-Davies, R. W.: Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma. Brit. J. Urol., 48: 55, 1976.
6. Abrams, P. H., Choa, R. G., Gaches, C. G. C., Ashken, M. H. and Green, N. A.: A controlled trial of single dose intravesical adriamycin in superficial bladder tumours. Brit. J. Urol., 53: 585, 1981.
7. Zincke, H., Utz, D. C., Taylor, W. F., Myers, R. P. and Leary, F. J.: Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial. J. Urol., 129: 505, 1983.
8. Kurth, K. H., Maksimovic, P. A., Hop, W. C. J., Schröder, F. H. and Bakker, N. J.: Single-dose intravesical epodyl after TUR of Ta TCC bladder carcinoma. World J. Urol., 1: 89, 1983.
9. Oosterlink, W., Kurth, K. H., Schröder, F. H., Bultinck, J., Hammond, B., Sylvester, R. and Members of the EORTC-GU Group: A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J. Urol., 149: 749, 1993.
10. Rajala, P., Kaasinen, E., Rintala, E., Jauhiainen, K., Nurmi, M., Alfthan, O. and Lähde, M.: Cytostatic effect of different strains of bacillus Calmette-Guerin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon alpha. Urol. Res., 20: 215, 1992.
11. Raitanen, M.-P. and Lukkarinen, O.: A controlled study of intravesical epirubicin with or without alpha2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder. Brit. J. Urol., 76: 697, 1995.
12. Harmer, M. H.: TNM Classification of Malignant Tumours, 3rd ed. Union Internationale Contre le Cancer. Geneva: World Health Organization, p. 113, 1978.
13. Mostofi, F. K., Sobin, L. H. and Torloni, H.: Histological Typing of Urinary Bladder Tumours. International Histological Classification of Tumours. Geneva: World Health Organization, 1973.
14. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer. Brit. J. Urol., 73: 632, 1994.
15. Tolley, D. A., Parmar, M. K. B., Grigor, K. M., Lallemand, G. and the Medical Research Council Superficial Bladder Cancer Working Party: The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of followup. J. Urol., 155: 1233, 1996.